The Cornwall Community Pharmacy Patient Activation Service – Type 2 Diabetes


‘Patient activation’ describes people’s knowledge, skills and confidence to manage their own health. Scores are closely linked to clinical outcomes, the costs of healthcare and patient experience. NHS England purchased Patient Activation Measure (PAM) licences to be used in Vanguard sites across the county to measure patient activation. Cornwall (NHS Kernow CCG) partnered with NHS South West Cardiovascular Clinical Network and Cornwall & Isles of Scilly Local Pharmaceutical Committee (LPC) to pilot a PAM service in community pharmacies in Cornwall for patients with type 2 diabetes mellitus (T2DM).It used PAM scoring and goal setting, combined with motivational interviewing in pharmacies, for individuals with T2DM, to understand how this might help them self-manage their condition. A total of315 patients were recruited to the service: 234 completed the full intervention; 29 formally withdrew, and the remainder were lost to follow up.Of those who completed the service, 98% either achieved (72%) or partially achieved (26%) their goals. PAM scores increased in 77% of patients by a mean of 8.64 points.

Back to the top

QiC Diabetes Highly Commended 2018
Patient Care Pathway, Generic or Specialist – Adults
The Cornwall Community Pharmacy Patient Activation Service – Type 2 Diabetes
by Cornwall Local Pharmaceuticals Committee (LPC)


Claire Field

Job title:
Pharmacist & Project Manager
Place of work:
Cornwall Local Pharmaceutical Committee (LPC), c/o Carbis Bay Pharmacy


Quality In Care Diabetes

  • 2020 KEY DATES
  • Open for entry: Wednesday 18 March 2020
  • Entry deadline: Thursday 2 July 2020
  • Judging day: Thursday 10 September 2020
  • Awards ceremony: Thursday 15 October 2020
QiC Diabetes is partnered by:
Supported by: